Abeterno

Abeterno Overview

Founded 2011
Founded
Status Out of Business
Employees 2
Employees
Latest Deal Type Liquidation

Abeterno General Information

Description

Developer of research tools for cell separation and live cell imaging. The company's research tools have developed novel cell isolation technology that makes use of magnetic nanoparticles to purify live cells using intracellular proteins.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • Cambridge
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abeterno Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation Completed Bankruptcy: Liquidation
1. Seed Round Completed Startup

Abeterno Executive Team (2)

Name Title Board Seat Contact Info
Rosalind Codrington Ph.D Founder & Chief Scientific Officer
Michael McLean Ph.D Board Member & Chief Executive Officer

Abeterno Board Members (3)

Name Representing Role Since
Alex Griffitths Abeterno Board of Director 000 0000
Linda Cammish Ph.D Abeterno Board of Director 000 0000
Michael McLean Ph.D Self Board Member & Chief Executive Officer 000 0000

Ready to get started?

Request a free trial